PetMed Express (PETS Quick QuotePETS - Free Report) is a Zacks Rank #1 (Strong Buy) and has a growth style score of A - all of that puts the stock in my radar screen.  Thing is, I have been watching this stock since the summer time when a short attack hit the stock and caused some wild swings.  

Previous Video

Back on September 7, I filmed this video which focuses on Aggressive Growth stocks.  You can access the video on this page (https://www.zacks.com/stock/news/275015/petmed-express-and-crox-are-aggressive-growth-rank-buys) and also hear about CROX as well.

Description

PetMed Express is a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. PetMed Express was founded in 1996 and is headquartered in Delray Beach, Florida.

Estimates

The stock is a Zacks Rank #1 (Strong Buy) because earnings estimates have moved higher.  The Zacks Consensus Estimate for 2017 has moved from $1.42 to $1.68 over the last sixty days.

The Zacks Consensus Estimate for 2018 also increased over the same time period. The number moved from $1.51 to $1.80.

Short Interest

There is a huge short interest in this stock.  That means that investors believe that the stock will move lower and they have borrowed shares, sold them and hope to buy them back lower.  Thing is, the short is not working.  The site ShortSqueeze.com shows that the float is 30% short... and that is a huge amount of shorts.

As fundamentals continue to improve, the shorts are more likely to cover their bets and take a loss.  This is could be a classic short squeeze.

Chart

PetMed Express, Inc. Price and Consensus

PetMed Express, Inc. Price and Consensus | PetMed Express, Inc. Quote

 

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>